Sunrest Lifescience Limited IPO
Sunrest Lifescience Limited was a SME IPO in the Pharmaceuticals sector, offered at ₹84–₹84 per share to raise ₹11 crore. It listed on 20 Nov 2023 at ₹84 and closed its first day at ₹80, a listing loss of -5.0% versus the ₹84 issue price. It now trades around ₹39 (-53.3% versus the issue price).
Frequently asked questions
- What were the Sunrest Lifescience Limited IPO listing gains?
- Sunrest Lifescience Limited listed on 20 Nov 2023 at ₹84, closing its first day at ₹80 — a listing loss of -5.0% versus the ₹84 issue price.
- What was the price band and lot size of the Sunrest Lifescience Limited IPO?
- The price band was ₹84–₹84 per share, with a minimum lot of 1,600 shares (₹1,34,400 at the upper band).
- Who were the registrar and lead manager for the Sunrest Lifescience Limited IPO?
- Skyline Financial Services Private Limited was the registrar, and Mark Corporate Advisors was the book-running lead manager.